SAVA
Filana Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.32
+2.33%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-24.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 25, 2025 | Anderson Robert Eugene Jr · director | Purchase | 8,600 | $2.90 |
| Nov 24, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 150,000 | $2.76 |
| Nov 20, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 73,385 | $2.75 |
| Oct 22, 2025 | Bir Dawn Carter · director | A-Award | 53,000 | $3.98 |
| Oct 2, 2025 | Cook Robert Christopher · officer: Chief Operating & Legal Office | Purchase | 13,725 | $2.91 |
| Sep 23, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 7,172 | $2.28 |
| Sep 22, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 400 | $2.25 |
| Sep 22, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 5,400 | $2.13 |
| Sep 22, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 185,233 | $2.24 |
| Sep 22, 2025 | Barry Richard · director, officer: President & CEO | Purchase | 46,908 | $2.29 |
| Jul 16, 2025 | SCANNON PATRICK J MD PHD · director | A-Award | 26,500 | $2.11 |
| May 27, 2025 | GUSSIN ROBERT Z · director | A-Award | 26,500 | $2.11 |
| May 27, 2025 | Gravier Pierre · director | A-Award | 26,500 | $2.11 |
| May 27, 2025 | Nicaise Claude · director | A-Award | 26,500 | $2.11 |
| May 27, 2025 | O DONNELL MICHAEL J · director | A-Award | 26,500 | $2.11 |
| May 27, 2025 | Anderson Robert Eugene Jr · director | A-Award | 26,500 | $2.11 |
| Apr 21, 2025 | Cook Robert Christopher · officer: Chief Operating & Legal Office | A-Award | 100,000 | $1.44 |
| Apr 21, 2025 | Barry Richard · director, officer: President & CEO | A-Award | 350,000 | $1.44 |
| Apr 21, 2025 | Schoen Eric · officer: Chief Financial Officer | A-Award | 100,000 | $1.44 |
| Apr 21, 2025 | Nassif Freda · officer: Chief Business Officer | A-Award | 100,000 | $1.44 |
| Dec 3, 2024 | Schoen Eric · officer: Chief Financial Officer | Sale | 2,000 | $3.82 |
| Dec 3, 2024 | Kupiec James William · officer: Chief Medical Officer | Sale | 4,000 | $3.87 |
| Dec 3, 2024 | Schoen Eric · officer: Chief Financial Officer | Sale | 59,800 | $3.86 |
| Dec 3, 2024 | Schoen Eric · officer: Chief Financial Officer | M-Exempt | 50,000 | $1.18 |
| Nov 20, 2024 | Landen Jaren · officer: Chief Clinical Dev. Officer | A-Award | 85,000 | $28 |
| Nov 20, 2024 | Nassif Freda · officer: Chief Commercial Officer | A-Award | 100,000 | $28 |
| Oct 1, 2024 | Barry Richard · director, officer: President & CEO | A-Award | 600,000 | $27 |
| Sep 9, 2024 | Kupiec James William · officer: Chief Medical Officer | A-Award | 100,000 | $27 |
| Sep 9, 2024 | Cook Robert Christopher · officer: SVP & General Counsel | A-Award | 100,000 | $27 |
| Sep 9, 2024 | Schoen Eric · officer: Chief Financial Officer | A-Award | 100,000 | $27 |
Institutional positioning
13F filings over the trailing two quarters
New 24Increased 36Reduced 76Sold out 23
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MARSHALL WACE, LLP | Reduced | 2,012,543 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 1,988,814 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,974,981 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,930,943 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 1,711,358 | Aug 14, 2026 |
| MARSHALL WACE, LLP | Reduced | 1,597,548 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 1,453,561 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 1,414,514 | May 13, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 749,178 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 668,792 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 615,510 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 596,242 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Increased | 559,205 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Reduced | 485,025 | Aug 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 478,017 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 25, 2025